Search

everythinglearnresearchcommunity

for

Search:↓

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Retinoids help manage skin conditions in black individuals.

Oral baricitinib is effective and safe for treating alopecia areata.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Acitretin treatment unexpectedly darkened a patient's gray hair.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

Ascorbyl Tetraisopalmitate penetrates skin better in the stratum corneum than in the infundibulum.

Tretinoin cream successfully treated a woman's skin condition called Fox-Fordyce disease.

The formulation with oleic acid may be better for treating male pattern baldness.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

Baricitinib is the most effective treatment for alopecia areata.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

A patient with complete hair loss regrew all her hair using tofacitinib.

Atopic dermatitis needs personalized treatment using various therapies, starting with topical corticosteroids.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Using Cyproterone Acetate with Eflornithine together is safe and works better for treating facial hair in women.

Many patients on new leukemia drugs had mild to moderate skin reactions.

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Oral isotretinoin effectively stabilizes frontal fibrosing alopecia.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.